Ameritas Investment Partners’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53.5K Hold
2,167
﹤0.01% 2051
2025
Q4
$36.6K Hold
2,167
﹤0.01% 2333
2025
Q3
$47.1K Sell
2,167
-450
-17% -$7.47K ﹤0.01% 2174
2025
Q2
$37.3K Buy
+2,617
New +$41.4K ﹤0.01% 2365
2021
Q2
Sell
-1,302
Closed -$10K 3109
2021
Q1
$10K Hold
1,302
﹤0.01% 2860
2020
Q4
$11K Hold
1,302
﹤0.01% 2743
2020
Q3
$10K Hold
1,302
﹤0.01% 2710
2020
Q2
$7K Buy
+1,302
New +$6.47K ﹤0.01% 2869

Other funds holding ETON

Ameritas Investment Partners's ETON Position: Q1 2026 in Review

Ameritas Investment Partners held its Eton Pharmaceutcials (ETON) position steady in Q1 2026 at 2,167 shares worth $53.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2051.

Ameritas Investment Partners first reported a position in ETON in Q2 2020 and has held it in 8 quarters since. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Ameritas Investment Partners held 2,167 shares of Eton Pharmaceutcials worth $53.5K as of Q1 2026.
  • Ameritas Investment Partners left its Eton Pharmaceutcials share count unchanged in Q1 2026.
  • Eton Pharmaceutcials made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2051 holding.
  • Ameritas Investment Partners first reported a position in Eton Pharmaceutcials in Q2 2020 and has held it in 8 quarters since.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.